Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
LetterLETTER

Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes

B.P. Kelley, P.A. Caruso and P.W. Schaefer
American Journal of Neuroradiology October 2019, 40 (10) E60-E61; DOI: https://doi.org/10.3174/ajnr.A6196
B.P. Kelley
aDepartment of Neuroradiology Massachusetts General Hospital Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for B.P. Kelley
P.A. Caruso
aDepartment of Neuroradiology Massachusetts General Hospital Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P.A. Caruso
P.W. Schaefer
aDepartment of Neuroradiology Massachusetts General Hospital Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P.W. Schaefer
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

We would like to commend Bulut et al1 for their investigation of brain MR imaging findings that could potentially be useful in discriminating pediatric-onset neuromyelitis optica spectrum disorder (NMOSD) from acute disseminated encephalomyelitis (ADEM). These 2 entities exist within the broader category of immune-mediated CNS disease, which is so challenging to diagnose prospectively, given the complexity, heterogeneity, and clinical-radiologic overlap between these different immune-mediated conditions. Given the current limitations in our understanding of the underlying pathophysiology of these disorders, we would like to take this opportunity to provide a historical context for this article and highlight a few recent studies from JAMA Neurology with larger cohorts that adopt a more granular neuro-imaging approach to disease characterization.

In their retrospective study of 10 pediatric patients with NMOSD and 10 pediatric patients with ADEM, Bulut et al identify MR imaging findings that could be potentially used to help differentiate NMOSD and ADEM in clinical practice. However, one must first acknowledge that, under the diagnostic criteria used in the study (2015 Consensus Diagnostic Criteria for NMOSD, https://www.ncbi.nlm.nih.gov/pubmed/26092914 and the 2007 Consensus Diagnostic Criteria for ADEM, https://www.ncbi.nlm.nih.gov/pubmed/17438241), it is possible for a single patient to meet both criteria. This highlights the tremendous clinical and radiologic overlap between these 2 general diagnostic categories and suggests that a NMOSD versus ADEM paradigm does not always allow adequate classification of the diseases. Even the term neuromyelitis optica (NMO) “spectrum disorder” implies that we currently lack an adequate understanding of the underlying pathophysiology to distinguish between specific entities within this 1 category, especially in the absence of antibodies against aquaporin-4 (AQP4), at least until another new causative autoantibody is identified. Similarly, ADEM is an umbrella term for entities often occurring after an infection or vaccination that share similar clinical phenotypes and imaging features, and it remains unclear how much of ADEM can be attributed to underlying autoantibodies such as those against myelin oligodendrocyte glycoprotein (MOG). Given these limitations, we should proceed with caution when drawing conclusions about MR imaging findings in these patients, especially when using small sample sizes and evolving disease classification systems.

In reality, patients in 2019 with new onset of immune-mediated CNS disease within the gray zone of NMOSD versus ADEM by imaging can end up with the clinical designation of ADEM if they meet the criteria for encephalopathy or present after a recent infection, but in some cases further discrimination can be rather arbitrary at initial presentation in the absence of positive anti-AQP4 or anti-MOG antibodies. This ongoing process of “greater discrimination through improved scientific understanding” is exemplified by the historical progression from “NMO is a variant of MS” to “NMO is a distinct antibody-mediated disease targeting AQP4” to “additional CNS antigens such as MOG can also be targeted by autoantibodies and result in a similar disease process.”2

JAMA Neurology published a series of studies in 2018–2019 that provides additional insight into how best to characterize MR imaging findings in pediatric patients with new onset of immune-mediated CNS disease. For readers interested in exploring this topic in more detail, we specifically want to highlight the work of the following authors: Hacohen et al3 wrote a prospective study of 102 pediatric patients with MOG antibody-associated disease (MOG Ab)–associated relaps-ing demyelinating syndromes initially given diagnoses of NMOSD, ADEM with subsequent optic neuritis, and multiphasic disseminated encephalomyelitis with relapsing optic neuritis who did not respond well to disease-modifying drugs but did respond to azathioprine, mycophenolate mofetil, rituximab and intravenous immunoglobulins. Dubey et al4 wrote a retrospective study of 54 patients, including 16 children and 38 adults with MOG immunoglobulin G–positive (MOG-IgG +) myelitis with various clinical presentations, including isolated transverse myelitis, acute flaccid myelitis, and myelitis in combination with ADEM or optic neuritis who had imaging characteristics distinct from MS and AQP4-IgG myelitis. López-Chiriboga et al5 wrote a retrospective study of 51 patients, including 31 children and 20 adults, with a clinical diagnosis of ADEM in which patients with persistent MOG Ab seropositivity had significantly higher rates of relapse.

It is always encouraging to see radiology contributing to the field of clinical research on NMOSD and ADEM that has largely been the domain of our neurology and pathology colleagues. Neuroimaging will continue to have a tremendous impact in our understanding of these diseases, but further translational research and interdisciplinary collaboration with large cohorts of patients will likely be required before we can reliably distinguish immune-mediated CNS diseases that are currently incompletely characterized but have similar clinical and radiologic phenotypes.

References

  1. 1.↵
    1. Bulut E,
    2. Karakaya J,
    3. Salama S, et al
    . Brain MRI findings in pediatric-onset neuromyelitis optica spectrum disorder: challenges in differentiation from acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2019;40:726–31 doi:10.3174/ajnr.A6003 pmid:30846436
    Abstract/FREE Full Text
  2. 2.↵
    1. Josep D
    . Autoimmunity: The good, the bad, and the ugly. Neurol Neuroimmunol Neuroinflamm 2015;2:e181 doi:10.1212/NXI.0000000000000181 pmid:26668820
    CrossRefPubMed
  3. 3.↵
    1. Hacohen Y,
    2. Wong YY,
    3. Lechner C, et al
    . Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody–associated disease. JAMA Neurol 2018;75:478–87 doi:10.1001/jamaneurol.2017.4601 pmid:29305608
    CrossRefPubMed
  4. 4.↵
    1. Dubey D,
    2. Pittock SJ,
    3. Krecke KN, et al
    . Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol 2019;76:301–09 doi:10.1001/jamaneurol.2018.4053
    CrossRefPubMed
  5. 5.↵
    1. López-Chiriboga AS,
    2. Majed M,
    3. Fryer J, et al
    . Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG–associated disorders. JAMA Neurol 2018;75:1355–63 doi:10.1001/jamaneurol.2018.1814 pmid:30014148
    CrossRefPubMed
  • © 2019 by American Journal of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 40 (10)
American Journal of Neuroradiology
Vol. 40, Issue 10
1 Oct 2019
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes
B.P. Kelley, P.A. Caruso, P.W. Schaefer
American Journal of Neuroradiology Oct 2019, 40 (10) E60-E61; DOI: 10.3174/ajnr.A6196

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes
B.P. Kelley, P.A. Caruso, P.W. Schaefer
American Journal of Neuroradiology Oct 2019, 40 (10) E60-E61; DOI: 10.3174/ajnr.A6196
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • Reply:
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Spine Microwave Ablation: Safety and Efficacy for Treatment of Vertebral Metastases
  • Reply:
  • The Complementary Role of CT Perfusion and Transcranial Doppler in the Assessment of Delayed Cerebral Ischemia after Aneurysmal SAH
Show more Letters

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2021 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2022 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire